BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 28442295)

  • 41. Tibetan medicine Ru-yi-Zhen-bao Pills exhibits anti-migraine effect through mediating PAG anti-nociceptive channel.
    Luo YM; Ren XQ; Yang XQ; Song HR; Li R; Gao MH; Li YR; Zhou RR; Ma L; Zhang SJ; Dong RJ; Ge DY; Wang CG; Ren QJ; Tao XH
    J Ethnopharmacol; 2020 Mar; 249():112437. PubMed ID: 31794788
    [TBL] [Abstract][Full Text] [Related]  

  • 42. SCFA Treatment Alleviates Pathological Signs of Migraine and Related Intestinal Alterations in a Mouse Model of NTG-Induced Migraine.
    Lanza M; Filippone A; Ardizzone A; Casili G; Paterniti I; Esposito E; Campolo M
    Cells; 2021 Oct; 10(10):. PubMed ID: 34685736
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Microglial NLRP3 inflammasome activation mediates IL-1β release and contributes to central sensitization in a recurrent nitroglycerin-induced migraine model.
    He W; Long T; Pan Q; Zhang S; Zhang Y; Zhang D; Qin G; Chen L; Zhou J
    J Neuroinflammation; 2019 Apr; 16(1):78. PubMed ID: 30971286
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Potentiation of endocannabinoids and other lipid amides prevents hyperalgesia and inflammation in a pre-clinical model of migraine.
    Greco R; Demartini C; Zanaboni AM; Francavilla M; Reggiani A; Realini N; Scarpelli R; Piomelli D; Tassorelli C
    J Headache Pain; 2022 Jul; 23(1):79. PubMed ID: 35799128
    [TBL] [Abstract][Full Text] [Related]  

  • 45. FAAH inhibition as a preventive treatment for migraine: A pre-clinical study.
    Greco R; Demartini C; Zanaboni AM; Tumelero E; Reggiani A; Misto A; Piomelli D; Tassorelli C
    Neurobiol Dis; 2020 Feb; 134():104624. PubMed ID: 31629892
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of protective effects of non-selective cannabinoid receptor agonist WIN 55,212-2 against the nitroglycerine-induced acute and chronic animal models of migraine: A mechanistic study.
    Mohammadi Vosough E; Baradaran Rahimi V; Masoud SA; Mirkarimi HR; Demneh MK; Abed A; Banafshe HR; Askari VR
    Life Sci; 2019 Sep; 232():116670. PubMed ID: 31330139
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Animal Model of Chronic Migraine-Associated Pain.
    Moye LS; Pradhan AAA
    Curr Protoc Neurosci; 2017 Jul; 80():9.60.1-9.60.9. PubMed ID: 28678396
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Nitroglycerin induces migraine headache and central sensitization phenomena in patients with migraine without aura: a study of laser evoked potentials.
    de Tommaso M; Libro G; Guido M; Difruscolo O; Losito L; Sardaro M; Cerbo R
    Neurosci Lett; 2004 Jun; 363(3):272-5. PubMed ID: 15182958
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of basolateral amygdala orexin 1 receptors on the modulation of pain and psychosocial deficits in nitroglycerin-induced migraine model in adult male rats.
    Askari-Zahabi K; Abbasnejad M; Kooshki R; Raoof M; Esmaeili-Mahani S; Pourrahimi AM; Zamyad M
    Korean J Pain; 2022 Jan; 35(1):22-32. PubMed ID: 34966009
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Rhynchophylline attenuates migraine in trigeminal nucleus caudalis in nitroglycerin-induced rat model by inhibiting MAPK/NF-кB signaling.
    Lai T; Chen L; Chen X; He J; Lv P; Ge H
    Mol Cell Biochem; 2019 Nov; 461(1-2):205-212. PubMed ID: 31420791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Evodiamine via targeting nNOS and AMPA receptor GluA1 inhibits nitroglycerin-induced migraine-like response.
    Lin J; Zhang X; Li C; Zhang Y; Lu H; Chen J; Li Z; Yang X; Wu Z
    J Ethnopharmacol; 2020 May; 254():112727. PubMed ID: 32147481
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Sphingosine-1 phosphate receptor 1 contributes to central sensitization in recurrent nitroglycerin-induced chronic migraine model.
    Pan Q; Wang Y; Tian R; Wen Q; Qin G; Zhang D; Chen L; Zhang Y; Zhou J
    J Headache Pain; 2022 Feb; 23(1):25. PubMed ID: 35144528
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The gut microbiome modulates nitroglycerin-induced migraine-related hyperalgesia in mice.
    Kang L; Tang W; Zhang Y; Zhang M; Liu J; Li Y; Kong S; Zhao D; Yu S
    Cephalalgia; 2022 May; 42(6):490-499. PubMed ID: 34644194
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The modulatory effect of anandamide on nitroglycerin-induced sensitization in the trigeminal system of the rat.
    Nagy-Grócz G; Tar L; Bohár Z; Fejes-Szabó A; Laborc KF; Spekker E; Vécsei L; Párdutz Á
    Cephalalgia; 2016 Aug; 36(9):849-61. PubMed ID: 26512068
    [TBL] [Abstract][Full Text] [Related]  

  • 55. α6GABA
    Tzeng HR; Lee MT; Fan PC; Knutson DE; Lai TH; Sieghart W; Cook J; Chiou LC
    Neurotherapeutics; 2021 Jan; 18(1):569-585. PubMed ID: 33111258
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Characterization of the peripheral FAAH inhibitor, URB937, in animal models of acute and chronic migraine.
    Greco R; Demartini C; Zanaboni A; Casini I; De Icco R; Reggiani A; Misto A; Piomelli D; Tassorelli C
    Neurobiol Dis; 2021 Jan; 147():105157. PubMed ID: 33129939
    [TBL] [Abstract][Full Text] [Related]  

  • 57. A novel, injury-free rodent model of vulnerability for assessment of acute and preventive therapies reveals temporal contributions of CGRP-receptor activation in migraine-like pain.
    Kopruszinski CM; Navratilova E; Swiokla J; Dodick DW; Chessell IP; Porreca F
    Cephalalgia; 2021 Mar; 41(3):305-317. PubMed ID: 32985222
    [TBL] [Abstract][Full Text] [Related]  

  • 58. The effect of intravenous administration of liposomal curcumin in addition to sumatriptan treatment in an experimental migraine model in rats.
    Bulboacă AE; Bolboacă SD; Stănescu IC; Sfrângeu CA; Porfire A; Tefas L; Bulboacă AC
    Int J Nanomedicine; 2018; 13():3093-3103. PubMed ID: 29872296
    [TBL] [Abstract][Full Text] [Related]  

  • 59. P2X7R-mediated autophagic impairment contributes to central sensitization in a chronic migraine model with recurrent nitroglycerin stimulation in mice.
    Jiang L; Zhang Y; Jing F; Long T; Qin G; Zhang D; Chen L; Zhou J
    J Neuroinflammation; 2021 Jan; 18(1):5. PubMed ID: 33402188
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Supplementation with SCFAs Re-Establishes Microbiota Composition and Attenuates Hyperalgesia and Pain in a Mouse Model of NTG-Induced Migraine.
    Lanza M; Filippone A; Casili G; Giuffrè L; Scuderi SA; Paterniti I; Campolo M; Cuzzocrea S; Esposito E
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.